SOR-C13 TFA, an extraordinary and highly specialized inhibitor deployed within the biomedical sphere for the purpose of combating cancer, embodies immense potency. Notably designed to single out sorafenib-resistant cells, it amplifies the efficacy of the widely employed sorafenib drug, primarily acclaimed for its profound impact against advanced renal cell carcinoma and liver malignancies.
CAT No: R2011
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.